CYTEK BIOSCIENCES INC
CTKBNASDAQTrading Snapshot
- Day Range
- $5.67 โ $5.79
- 52-Week Range
- $3.31 โ $6.18
- Volume
- $1.81B
- Avg Volume
- $2.39B
- Shares Outstanding
- 129.1M
- Next Earnings
- Dec 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $201M
- Last Q Revenue
- $48M
- P/E Ratio
- -9.2
- P/S Ratio
- 3.6x
- EPS (TTM)
- $-0.62
- Dividend Yield
- 0.00%
- Dilution (1yr)
- โ0.8%
Why Investors Own CTKB
- โHigh-growth profile โ revenue up +29.6% YoY with expanding US Equity exposure.
- โHealthy economics โ 35% gross margin and 28% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CYTEK BIOSCIENCES INC
CTKBAbout CYTEK BIOSCIENCES INC
Cytek Biosciences, Inc. is a company dedicated to cell analysis solutions, offering advanced tools that facilitate scientific progress in both biomedical research and clinical settings. Their primary offerings include the Aurora and Northern Lights spectrum flow cytometers. These instruments conduct comprehensive cell analysis by leveraging fluorescence signatures from multiple lasers to differentiate between various fluorescent tags on individual cells. Complementing these, the Aurora Cell Sorter system utilizes full spectrum profiling technology to broaden the range of potential applications in cell analysis. Beyond instrumentation, Cytek provides essential reagents and kits. These include cFluor reagents, which are antibodies conjugated with fluorochromes, specifically designed to identify target cells for analysis on their systems. They also offer a 25-color immunoprofiling assay, a ready-to-use solution for pinpointing major human immune cell subpopulations like TBNK cells, monocytes, dendritic cells, and basophils. To streamline laboratory operations, the company offers automated micro-sampling and sample loader systems. These automated plate loaders are engineered to integrate seamlessly with the Aurora and Northern Lights systems. The intuitive SpectroFlo software accompanies these systems, simplifying the workflow from quality control through to data analysis. Cytek also provides comprehensive customer support resources. Cytek's diverse client base includes pharmaceutical and biopharmaceutical companies, academic research institutions, and clinical research organizations. The company distributes its products through a direct sales force and dedicated support teams in North America, Europe, China, and the Asia-Pacific region. Additionally, it partners with distributors and sales agents to serve markets across European, Latin American, Middle Eastern, and other Asia-Pacific countries. Originally established in 1992 as Cytoville, Inc., the company officially adopted the name Cytek Biosciences, Inc. in August 2015. Its corporate headquarters are situated in Fremont, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Analyst Price Target
โLatest News & Updates

1,315,332 Shares in Cytek Biosciences, Inc. $CTKB Acquired by Bank of America Corp DE
Bank of America Corp DE purchased a new position in shares of Cytek Biosciences, Inc. (NASDAQ: CTKB) during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commi

Cytekยฎ Biosciences Extends Capabilities Within Cytek Cloud Digital Ecosystem with New Cloud Analysis Tool
Cytek has expanded its Cytekยฎ Cloud digital ecosystem with a new Cloud Analysis tool to create the industry's first end-to-end flow cytometry platform.

Critical Survey: Revvity (NYSE:RVTY) vs. Cytek Biosciences (NASDAQ:CTKB)
Revvity (NYSE: RVTY - Get Free Report) and Cytek Biosciences (NASDAQ: CTKB - Get Free Report) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of

Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock?
Investors need to pay close attention to CTKB stock based on the movements in the options market lately.

Cytek Biosciences, Inc. (CTKB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Cytek Biosciences, Inc. (CTKB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Sysmex Europe and Cytekยฎ Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry
FREMONT, Calif., and HAMBURG, Germany, Sept.